Previous Article | Next Article 
Journal of Virology, February 2006, p. 1645-1652, Vol. 80, No. 4
0022-538X/06/$08.00+0 doi:10.1128/JVI.80.4.1645-1652.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Generation of CD8+ T-Cell Responses by a Recombinant Nonpathogenic Mycobacterium smegmatis Vaccine Vector Expressing Human Immunodeficiency Virus Type 1 Env
Mark J. Cayabyab,1
Avi-Hai Hovav,1
Tsungda Hsu,2
Georgia R. Krivulka,1
Michelle A. Lifton,1
Darci A. Gorgone,1
Glenn J. Fennelly,3
Barton F. Haynes,4
William R. Jacobs Jr.,2 and
Norman L. Letvin1*
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215,1
Department of Microbiology and Immunology, Howard Hughes Medical Institute,2
Department of Pediatrics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461,3
Duke University School of Medicine, Durham, North Carolina 277104
Received 25 August 2005/
Accepted 30 November 2005
Because the vaccine vectors currently being evaluated in human populations all have significant limitations in their immunogenicity, novel vaccine strategies are needed for the elicitation of cell-mediated immunity. The nonpathogenic, rapidly growing mycobacterium Mycobacterium smegmatis was engineered as a vector expressing full-length human immunodeficiency virus type 1 (HIV-1) HXBc2 envelope protein. Immunization of mice with recombinant M. smegmatis led to the expansion of major histocompatibility complex class I-restricted HIV-1 epitope-specific CD8+ T cells that were cytolytic and secreted gamma interferon. Effector and memory T lymphocytes were elicited, and repeated immunization generated a stable central memory pool of virus-specific cells. Importantly, preexisting immunity to Mycobacterium bovis BCG had only a marginal effect on the immunogenicity of recombinant M. smegmatis. This mycobacterium may therefore be a useful vaccine vector.
* Corresponding author. Mailing address: Department of Medicine, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave., Boston, MA 02130. Phone: (617) 667-2042. Fax: (617) 667-8210. E-mail:
nletvin{at}bidmc.harvard.edu.
Journal of Virology, February 2006, p. 1645-1652, Vol. 80, No. 4
0022-538X/06/$08.00+0 doi:10.1128/JVI.80.4.1645-1652.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Cayabyab, M. J., Korioth-Schmitz, B., Sun, Y., Carville, A., Balachandran, H., Miura, A., Carlson, K. R., Buzby, A. P., Haynes, B. F., Jacobs, W. R., Letvin, N. L.
(2009). Recombinant Mycobacterium bovis BCG Prime-Recombinant Adenovirus Boost Vaccination in Rhesus Monkeys Elicits Robust Polyfunctional Simian Immunodeficiency Virus-Specific T-Cell Responses. J. Virol.
83: 5505-5513
[Abstract]
[Full Text]
-
Bueno, S. M., Gonzalez, P. A., Cautivo, K. M., Mora, J. E., Leiva, E. D., Tobar, H. E., Fennelly, G. J., Eugenin, E. A., Jacobs, W. R. Jr., Riedel, C. A., Kalergis, A. M.
(2008). Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc. Natl. Acad. Sci. USA
105: 20822-20827
[Abstract]
[Full Text]
-
Mo, Y., Quanquin, N. M., Vecino, W. H., Ranganathan, U. D., Tesfa, L., Bourn, W., Derbyshire, K. M., Letvin, N. L., Jacobs, W. R. Jr., Fennelly, G. J.
(2007). Genetic Alteration of Mycobacterium smegmatis To Improve Mycobacterium-Mediated Transfer of Plasmid DNA into Mammalian Cells and DNA Immunization. Infect. Immun.
75: 4804-4816
[Abstract]
[Full Text]
-
Im, E.-J., Saubi, N., Virgili, G., Sander, C., Teoh, D., Gatell, J. M., McShane, H., Joseph, J., Hanke, T.
(2007). Vaccine Platform for Prevention of Tuberculosis and Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1 through Breastfeeding. J. Virol.
81: 9408-9418
[Abstract]
[Full Text]
-
Yu, J.-S., Peacock, J. W., Jacobs, W. R. Jr., Frothingham, R., Letvin, N. L., Liao, H.-X., Haynes, B. F.
(2007). Recombinant Mycobacterium bovis Bacillus Calmette-Guerin Elicits Human Immunodeficiency Virus Type 1 Envelope-Specific T Lymphocytes at Mucosal Sites. CVI
14: 886-893
[Abstract]
[Full Text]
-
Hovav, A.-H., Cayabyab, M. J., Panas, M. W., Santra, S., Greenland, J., Geiben, R., Haynes, B. F., Jacobs, W. R. Jr., Letvin, N. L.
(2007). Rapid Memory CD8+ T-Lymphocyte Induction through Priming with Recombinant Mycobacterium smegmatis. J. Virol.
81: 74-83
[Abstract]
[Full Text]
-
Yu, J.-S., Peacock, J. W., Vanleeuwen, S., Hsu, T., Jacobs, W. R. Jr., Cayabyab, M. J., Letvin, N. L., Frothingham, R., Staats, H. F., Liao, H.-X., Haynes, B. F.
(2006). Generation of Mucosal Anti-Human Immunodeficiency Virus Type 1 T-Cell Responses by Recombinant Mycobacterium smegmatis{triangledown}. CVI
13: 1204-1211
[Abstract]
[Full Text]
-
Bolesta, E., Kowalczyk, A., Wierzbicki, A., Eppolito, C., Kaneko, Y., Takiguchi, M., Stamatatos, L., Shrikant, P. A., Kozbor, D.
(2006). Increased Level and Longevity of Protective Immune Responses Induced by DNA Vaccine Expressing the HIV-1 Env Glycoprotein when Combined with IL-21 and IL-15 Gene Delivery. J. Immunol.
177: 177-191
[Abstract]
[Full Text]